LA JOLLA PHARMACEUTICAL CO of WALTHAM, MA filed a DEFA14A with the SEC on 2020-05-04. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | GRAPHIC | lajolla2019proxy01page1.jpg |
| 3 | GRAPHIC | lajolla2019proxy01page2.jpg |
| 4 | GRAPHIC | lajolla2019proxy01page3.jpg |
| 5 | GRAPHIC | lajolla2019proxy01page4.jpg |
Showing 12 of 58 filings.
| Filed | Form |
|---|---|
| 2022-08-22 | SC 14D9/A |
| 2022-08-15 | SC 14D9/A |
| 2022-07-25 | SC 14D9 |
| 2022-07-12 | SC14D9C |
| 2021-06-04 | DEFA14A |
| 2021-06-04 | DEF 14A |
| 2021-05-25 | PRE 14A |
| 2020-05-12 | SC TO-C |
| 2020-05-04 | DEFA14A |
| 2020-04-29 | DEF 14A |
| 2019-09-18 | DEF 14A |
| 2018-08-22 | DEF 14A |